SurgOnc Today®-logo

SurgOnc Today®

Science Podcasts

SurgOnc Today® is an educational podcast for cancer surgeons from the Society of Surgical Oncology. Each episode features conversations with individuals who are experts within their respective fields and are members of SSO.

Location:

United States

Description:

SurgOnc Today® is an educational podcast for cancer surgeons from the Society of Surgical Oncology. Each episode features conversations with individuals who are experts within their respective fields and are members of SSO.

Twitter:

@SocSurgOnc

Language:

English


Episodes
Ask host to enable sharing for playback control

SSO Education Series: Indigenous Peoples: Cancer Care and the Research the Drives It

11/7/2024
This podcast was recorded on September 30, which is the National Day for Truth and Reconciliation in Canada and features an interview with Dr. Nadine Caron, who was the first Indigenous female surgeon in Canada. Dr. Caron shares her experience and perspectives from her leadership roles in health equity for First Nations peoples in Northern British Columbia with Dr. Cord Sturgeon and Dr. Masha Javid. The conversation explores the inequities in cancer care and cancer outcomes among Indigenous Peoples. Cancer incidence and survival among Indigenous People, gaps in knowledge, drivers of inequity, and a path forward for developing trust are discussed.

Duration:00:47:01

Ask host to enable sharing for playback control

SOI Article Series: The Prognostic Role of Post-operative cfDNA after Resection of Colorectal Liver Metastases: A Systematic Review and Meta-Analysis

11/4/2024
In this inaugural episode of the Surgical Oncology Insight series of SurgOnc Today®, Dr. Shishir Maithel, Editor of Surgical Oncology Insight, SSO's open-access journal, discusses with Dr. Brett Ecker the results of a systematic review and meta-analysis characterizing the incidence of cfDNA-positivity after resection of colorectal cancer liver metastases with quantification of its sensitivity and specificity for postoperative recurrence, as reported in his article, "The Prognostic Role of Post-operative cfDNA after Resection of Colorectal Liver Metastases: A Systematic Review and Meta-Analysis."

Duration:00:14:24

Ask host to enable sharing for playback control

Superficial Soft Tissue Sarcoma

9/26/2024
The surgical management of superficial soft tissue sarcoma require a multidisciplinary surgical team given the defect and reconstruction required from an extended resection to achieve negative margins. This team most often includes the primary surgeon (surgical oncology or orthopedic oncology) and a plastic surgeon. A critical decision in the treatment plan is whether or not to reconstruct immediately at the index operation or delay final reconstruction pending pathologic assessment of margins. In this podcast, we will focus on the multidisciplinary surgical approach for superficial sarcoma. We will highlight the role of delayed reconstruction and key clinical considerations in this approach.

Duration:00:21:31

Ask host to enable sharing for playback control

ASCO 2024 Melanoma Updates for Surgical Oncologists

9/12/2024
Please listen in as Drs. Piltin, van Akkooi, and Hyngstrom discuss relevant clinical trial presentations from ASCO 2024 annual meeting and their impressions on the implications for surgical oncologists. Abstracts results discussed include the neoadjuvant NADINA and PIVOTAL trials as well as an initial report on upfront TIL therapy for stage IV patients.

Duration:00:22:05

Ask host to enable sharing for playback control

Is a Diverting Ostomy Needed for All Rectal Resections?

8/29/2024
In this episode of SurgOnc Today®, Dr. Patrick Sullivan is joined by Dr. Nicole Lopez and Dr. César Reátegui to discuss diverting ostomy. Current practice guidelines suggest that diverting ostomy is the standard of care in surgical management of rectal cancer after neoadjuvant therapy to minimize the risk of clinically significant leak which can then result in permanent colostomy. However, the risk of anastomotic leak after neoadjuvant chemoradiation ranges from 4-12% suggesting that most patients have unnecessary ostomy and additional surgery. With improvement of surgical techniques, utilization of robotic surgery and recent adoption of more TNT approaches, selective use of diverting ostomy will lead to improvement in QOL and decrease in health care costs with minimal impact on incidence of permanent colostomy.

Duration:00:19:56

Ask host to enable sharing for playback control

Guidelines for Genetic Testing for Breast Cancer

8/22/2024
In this podcast, the relatively new ASCO guidelines for breast cancer genetic testing will be discussed. The differences between these and other guidelines, such as ASBrS and NCCN, will be discussed. In addition, the different testing options and implications of positive results will be reviewed.

Duration:00:16:25

Ask host to enable sharing for playback control

Implementation of International Cancer Quality Standards in Developing Countries

8/15/2024
The podcast will explore different barriers to implement international cancer quality standards in developing countries, approach to overcome these barriers and how the SSO can help and support access to world class cancer care in developing countries. This episode is led by Dr. Cherif Boutros, who is joined by Dr. Nader Hanna and Dr. Joseph Espat.

Duration:00:22:41

Ask host to enable sharing for playback control

AHPBA 2024 Recap

8/8/2024
In this episode of SurgOnc Today®, Dr. Julie Hallet, Chair of the SSO HPB Disease Site Working Group, reviews key updates and takeaways from the recent AHPBA Annual Meeting held in April 2024 in Miami. They are joined by Dr. Miral Grandhi, Dr. Amer Zureikat, Dr. Rebecca Snyder, and Dr. Katrina Duncan to review clinical trials on blood management for liver resection, biliary decompression for Klatskin tumors, and total venous deprivation to generate liver hypertrophy, as well as new data on genomics of pancreatic neuroendocrine tumors and bile liquid biopsy, and why evidence from clinical trials may not be adopted in HPB surgery.

Duration:00:24:20

Ask host to enable sharing for playback control

Neoadjuvant Therapy Trials for Pancreas Cancer Conundrum: The European Take: PREOPANC2, NORPACT

8/1/2024
In this episode of SurgOnc Today®, Akhil Chawla, MD, from Northwestern University, and a member of the SSO HPB disease site working group, is joined by Bas Groot Koerkamp, MD, PhD, from Erasmus Medical Centre and Knut Jørgen Labori, MD, PhD, from Oslo University Hospital. They discuss the details, similarities, and differences of their respective clinical trials for neoadjuvant therapy for pancreatic adenocarcinoma, NORPACT-1 and PREOPANC2. References/Resources: NORPACT-1 results: https://www.sciencedirect.com/science/article/abs/pii/S2468125323004053?via%3Dihub NORPACT-1 editorial: https://pubmed.ncbi.nlm.nih.gov/38604195/ PREOPANC-2 protocol: https://bmccancer.biomedcentral.com/articles/10.1186/s12885-021-08031-z PREOPANC-2 results : https://www.annalsofoncology.org/article/S0923-7534(23)04228-X/fulltext

Duration:00:21:42

Ask host to enable sharing for playback control

Recap of ACT 2024

7/25/2024
In this episode of SurgOnc Today®, Deepa Magge, MD, and Abhineet Uppal, MD, provide a recap of highlights from the SSO Advanced Cancer Therapies conference held in February 2024.

Duration:00:17:52

Ask host to enable sharing for playback control

Update on Molecular Testing for Thyroid Nodules and Where We Are In 2023-2024

7/18/2024
In this episode of SurgOnc Today®, Yinin Hu, MD, and Sarah Fisher, MD, are joined by Neal Saunders, MD, and Heather Wachtel, MD, for a discussion of molecular testing for thyroid nodules and how to incorporate this adjunct into clinical practice.

Duration:00:27:35

Ask host to enable sharing for playback control

Updates from the 25th Annual Meeting of the American Society of Breast Surgeons

7/11/2024
In this episode of SurgOnc Today®, Doreen Agnese, MD, and Sarah Blair, MD, discuss data presented at the 25th Annual Meeting of the American Society of Breast Surgeons, including updates on cryoablation, use of immediate lymphatic reconstruction, decision aids in management of DCIS, surgical complications in patients treated with immunotherapy for ER positive tumors, and quality of life in older patients treated with endocrine therapy.

Duration:00:11:22

Ask host to enable sharing for playback control

Hope Renewed: A Young Woman's Journey after CRS/HIPEC

6/27/2024
In this episode of SurgOnc Today®, Dr. Melanie Ongchin from the University of Pittsburgh, Dr. Trang Nguyen from Washington University, and Dr. Molly Kledzik from WVU are joined by Ms. Lindsay Barad, a patient and advocate for PMP Pals. Diagnosed with LAMN with PMP, Lindsay shares her unique perspective on the patient experience following CRS/HIPEC, emphasizing the challenges and considerations of young female patients regarding fertility.

Duration:00:17:52

Ask host to enable sharing for playback control

Management of Atypical Lipomatous Tumor / Well-differentiated Liposarcoma, Episode 3

6/20/2024
This episode of SurgOnc Today is episode 3 of our Management of ALT/WDLPS series. Dr. Brian Kadera, Dr. Jessica Cintolo-Gonzalez and Dr. John Miura will discuss surveillance and treatment approaches for recurrent well-differentiated liposarcoma (WDLPS) in the retroperitoneum, which has a very high rate of recurrence. Even after radical resections by experienced surgeons, these tumors can recur a decade later. They will review the natural history of late-stage WDLPS, the actual risk of transformation from well-differentiated to dedifferentiated liposarcoma (WD to DD), and a multidisciplinary treatment approach to unresectable recurrences.

Duration:00:27:32

Ask host to enable sharing for playback control

Lifestyle Medicine Perspectives on Staying Well as a Surgeon—Exercise, Nutrition, Health and Happiness

6/12/2024
In this episode of SurgOnc Today®, we talk with Dawn Mussallem, DO, a certified lifestyle medicine physician. She helps us walk through the importance of staying healthy and provides thoughts and suggestions for healthy living. We discuss exercise, nutrition, health and happiness.

Duration:00:51:07

Ask host to enable sharing for playback control

Highlighting Surgical Oncology Leaders of AANHPI Heritage

5/30/2024
On this episode of SurgOnc Today®, in honor of Asian American Native Hawaiian Pacific Islander (AANHPI) month, we highlight the achievements and contributions of those with AANHPI background and their involvement in surgical oncology care. Today we speak with some of the AANHPI leaders in surgical oncology around the US, providing insight into how their upbringing/heritage affected their careers in medicine. Moderators: Tammy Ju Faculty: Vikas Dudeja, Anai Kothari

Duration:00:25:45

Ask host to enable sharing for playback control

Management of Synchronous Rectal Cancer with Liver Metastases

5/16/2024
In this episode of SurgOnc Today, Alexander Parikh, MD, MPH, from the University of Texas – San Antonio and Chair of the SSO HPB disease site working group, and Laleh G. Melstrom, MD, MSCI, from City of Hope National Medical Center, are joined by Timothy Newhook, MD, from the University of Texas MD Anderson Cancer Center and Andreas Kaiser, MD, from the City of Hope. We will be discussing the management of synchronous rectal cancer with liver metastases.

Duration:00:35:18

Ask host to enable sharing for playback control

CGSO Fellowship and Preparing Surgeons for Community Practice

5/9/2024
In this episode of SurgOnc Today, Brian Sparkman, MD, is joined by Lily Lai, MD, Margo Shoup, MD, MBA, and Kristen Massimino, MD, to discuss how CGSO fellowships prepare surgeons for a career in community practice and how we might improve this in the future. Show Notes: Medical students are caught in the residency 'research arms race' - STAT - https://www.statnews.com/2024/04/29/research-arms-race-medical-students-residency-applications/ Behrens S, Ann Surg Oncol. 2024 Jan; 31(1):31-42. DOI: 10.1245/s10434-023-14524-x Clarke CN. Surg Oncol Clin N Am. 2022 Jan; 31910: 21 – 27. DOI: 10.1016/j.soc.2021.07.004 Wach MW. Ann Surg Oncol. 2019 Sep; 26(9):2675-2681. DOI: 10.1245/s10434-019-07372-1

Duration:00:33:26

Ask host to enable sharing for playback control

Management of High Grade Well Differentiated Neuroendocrine Tumors

4/25/2024
In this episode of SurgOnc Today®, Sonia Orcutt, MD and Michail Mavros, MD, from the University of Arkansas for Medical Sciences are joined by Callisia N. Clarke, MD, MS, FACS, FSSO, Chief of the Division of Surgical Oncology at the Medical College of Wisconsin, and Alexandra Gangi, MD, FSSO, Director of the Gastrointestinal Tumor Program at Cedars Sinai Medical Center. The optimal treatment of high-grade well-differentiated neuroendocrine tumors has not been well-described, as they have only in recent years been identified as distinct from neuroendocrine carcinomas. The panelists discuss the most up-to-date information on diagnosis and management of gastroenteropancreatic high-grade well differentiated neuroendocrine tumors.

Duration:00:24:31

Ask host to enable sharing for playback control

Nuts and Bolts of Surgical Management of Perihilar Cholangiocarcinoma – Part 2

4/25/2024
In this episode of SurgOnc Today, live from SSO 2024, Dr. Alex Parikh from the University of Texas – San Antonio and Chair of the SSO HPB disease site working group, and Dr. Julie Hallet from the University of Toronto, and Vice-Chair of the SSO HPB disease site working group, are joined by Dr. Ana Gleisner from the University of Colorado and Dr. Skye Mayo from the Oregon Health and Sciences University. They will be discussing two important aspects of the surgical management of perihilar cholangiocarcinoma: determining resectability as it relates to vascular involvement, and the role of neoadjuvant therapy.

Duration:00:33:07